Microsatellite analysis of urine sediment versus urine cytology for diagnosing transitional cell tumors of the urinary bladder. 2004

Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
Department of Pathology, Herlev University Hospital of Copenhagen, Denmark. DEFO@herlevhosp.kbhamt.dk

The aim was to evaluate microsatellite analysis of urine sediment (MAUS) as an alternative method to urine cytology for routine diagnosis of patients with transitional cell tumors (TCT) of the urinary bladder. Urine cytology has the advantage of being non-invasive, fast and cheap, but is of limited value because of its low sensitivity. MAUS has previously been found to be a successful alternative method. However, the experimental set-up of such investigations implied exclusion of samples with unfavorable characteristics and use of a large number of markers. In the present study, MAUS was tested on all samples routinely available and a small panel of markers was selected. The urine sediments of 66 TCT patients and 24 controls were analyzed by MAUS with 16 fluorescent markers and by urine cytology. All samples were analyzed, including the ones of later micturition, with gross hematuria, leukocyturia or absence of visible sediment. In patients with tumors of low grade (grades I-II), MAUS was significantly more sensitive than urine cytology. The two methods were of equivalent diagnostic power in high-grade (grades III-IV), high-stage (pT1-pT4) tumors. A panel of the six most informative markers for MAUS was selected. Although MAUS has an advantage over routine cytology in low-grade, low-stage tumors, an overall sensitivity of 45% is not sufficient for routine clinical use.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
January 2006, Oncology reports,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
June 2006, The Journal of urology,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
October 2001, International journal of cancer,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
January 2003, Anticancer research,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
September 2003, Actas urologicas espanolas,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
January 1975, Acta cytologica,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
December 1983, Harefuah,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
March 2005, Oncology reports,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
August 2000, Cancer research,
Delfina Fornari, and Kenneth Steven, and Alastair B Hansen, and Henrik Vibits, and Jan V Jepsen, and Asger L Poulsen, and Marianne Schwartz, and Thomas Horn
August 2007, Oncology reports,
Copied contents to your clipboard!